Kidney Stone Management Market Report 2025

The kidney stone management market size has grown strongly in recent years. It will grow from $2.3 billion in 2024 to $2.46 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the rising prevalence of kidney stones, increasing obesity rates, an expanding aging population, growing awareness of kidney health, and improved access to healthcare services.

The kidney stone management market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to an increasing aging population, greater adoption of minimally invasive procedures, rising utilization of advanced imaging technologies, expansion of telehealth and digital health solutions, growing healthcare expenditure, and heightened awareness of kidney health. Major trends during this period include innovations in non-invasive treatment technologies, AI-powered diagnostics, miniaturized surgical instruments, enhanced imaging techniques, smart wearable monitoring devices, precision-targeted therapies, and improved telehealth integration.

The increasing prevalence of chronic kidney disease (CKD) is expected to drive the growth of the kidney stone management market in the coming years. CKD refers to the gradual decline in kidney function over time, often caused by diabetes, high blood pressure, and genetic factors. The rise in CKD is largely attributed to the growing prevalence of diabetes, a major contributor to long-term kidney damage. Kidney stone management supports individuals with CKD by preventing blockages and infections, protecting the kidneys from further damage, and helping maintain their function. For example, according to the Australian Institute of Health and Welfare, a government agency in Australia, CKD mortality rates rose by 4.2% in 2021 and 6.2% in 2022. During 2021-22, CKD was recorded in approximately 2 million hospitalizations, accounting for 18% of all hospitalizations in Australia. Consequently, the growing prevalence of CKD is fueling the expansion of the kidney stone management market.

Key players in the kidney stone management market are focusing on developing innovative solutions, such as the Ascend ureteroscopes, to provide comprehensive urology care. The Ascend ureteroscope offers flexible endoscopic access to the urinary tract, including the ureter and kidney, enabling visualization, diagnosis, and treatment of conditions such as kidney stones. In May 2024, Cook Medical Inc., a US-based medical device company, launched the Ascend single-use ureteroscope, a disposable endoscopic device for urologic procedures, particularly kidney stone management. The device features a 275-degree up/down deflection and a deflection lock to maintain the selected angle, enhancing precision during challenging procedures. Additionally, the Ascend ureteroscope is approved for Medicare’s Transitional Pass-through (TPT) payment scheme, increasing its accessibility in clinical practice.

In September 2022, Advanced MedTech Holdings, a Germany-based medical device company, acquired WIKKON for an undisclosed sum. This acquisition strengthens Advanced MedTech’s presence in China and other emerging global markets by combining German engineering with localized innovation. The deal expands its urology product portfolio, enhances manufacturing capabilities, and aligns with China’s domestic sourcing strategy. WIKKON is a China-based manufacturer of shock wave therapy devices used for kidney stone management.

Major players in the kidney stone management market are Medtronic plc, Siemens Healthineers AG, C.R. Bard Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Karl Storz GmbH & Co. KG, Cook Medical Inc., Richard Wolf GmbH, Lumenis Ltd., MorphoSys AG, Dornier MedTech, EDAP TMS S.A., E.M.S. Electro Medical Systems S.A., Dyax Corp., STORZ MEDICAL AG, Medispec Ltd., DirexGroup SA, and Elmed Medical Systems Ltd.

North America was the largest region in the kidney stone management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in kidney stone management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the kidney stone management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Kidney stone management refers to a comprehensive medical approach focused on diagnosing, monitoring, and treating solid mineral deposits in the kidneys. This approach aims to relieve symptoms, remove existing stones, and prevent recurrence, taking into account factors such as stone composition, size, location, and the patient’s overall health.

The primary treatments for kidney stone management include extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, percutaneous nephrolithotomy (PCNL), and other procedures. Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive therapy that uses high-energy shock waves generated outside the body to break kidney, ureter, or other duct stones into smaller fragments. Key product types include lithotripters, stone removal baskets, ureteral stents, and ureterorenoscopes. Diagnostic methods include abdominal X-rays, computed tomography (CT), ultrasound, abdominal MRI, intravenous pyelography, and others. These products are distributed through retail and online pharmacies, among other channels, and are used by end users such as hospitals, specialty clinics, and ambulatory surgical centers.

The kidney stone management market research report is one of a series of new reports that provides kidney stone management market statistics, including the kidney stone management industry global market size, regional shares, competitors with the kidney stone management market share, detailed kidney stone management market segments, market trends, and opportunities, and any further data you may need to thrive in the kidney stone management industry. This kidney stone management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The kidney stone management market consists of revenues earned by entities by providing services such as advanced diagnostic services, minimally invasive treatment procedures, medical consultations and therapeutic interventions, post-procedure care, and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney stone management market also includes sales of stone retrieval devices, ureteral stents, and catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.